|
|
|
|
| LEADER |
00000cam a2200000 7i4500 |
| 001 |
0000091762 |
| 005 |
20170828093000.0 |
| 008 |
170530s2015 nyu eng |
| 020 |
|
|
|a 9781634637015 vol.1
|
| 020 |
|
|
|a 9781634637022 vol.2
|
| 050 |
0 |
0 |
|a RC684.A53
|b A24 2015
|
| 060 |
1 |
0 |
|a QU 136
|b .A173 2015
|
| 090 |
0 |
0 |
|a RC684.A53
|b A24 2015
|
| 245 |
0 |
0 |
|a Ace inhibitors :
|b medical uses, mechanisms of action, potential adverse effects and related topics
|c editor Macaulay Amechi Onuigbo
|
| 260 |
|
|
|a New York :
|b Nova Biomedical ,
|c c2015
|
| 300 |
|
|
|a 2 vol. :
|b ill. ;
|c 26 cm.
|
| 504 |
|
|
|a Includes bibliographical references and index
|
| 505 |
0 |
|
|a 1. The introduction of angiotensin converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) into clinical medicine and the mechanisms of actions of ACEIs and ARBs -- 2. RCTs revisited: a nephrologist's critique of randomized controlled trials in the nephrology literature -- 3. The abuse of renal surrogates and combination renal endpoints in nephrology RCTs -- 4. The CKD enigma, reengineering CKD care, narrowing asymmetric information and confronting ethicomedicinomics in CKD care: the introduction of the new 'CKD express 'IT sofeware program -- 5. The "triple whammy" challenge revisited - ACEIs, diuretics and NSAIDs: a European 21st century perspective -- 6. "Quadruple whammy": a newly described preventable syndrome of peri-operative AKI on CKD in patients on concurrent "triple whammy" medications -- 7. Late onset renal failure from angiotensin blockade (LORFFAB) - the results of a mayo clinic health system angiotensin inhibition withdrawal study: a clarion call for more preventative nephrology, also called renoprevention -- 8. Acute kidney injury on chronic kidney disease - the rainbow syndrome of too many colors: a mayo clinic health system case series report -- 9. The syndrome of rapid onset ESRD in the ast 100 consecutive incident northewstern wisconsin mayo clinic chronic hemodialysis patients, 2010-2011: results of the analysis of individual patient-level serum creatinine trajectories to ESRD - can there be a link with angiotensin inhibition and renal senescence in older CKD patients? -- 10. Geriatric nephrology debate: angiotensin inhibition should be withdrawn in older adults with later stage CKD: a 2013 mayo clinic health system nephrologist's and the unmet need for newer kidney-friendly renoprotective agents for the 21st century -- 11. Zefenopril: a sulphydryl ACE inhibitor endowed with antioxidant and cardioprotective endowed with antioxidant and cardioprotective activity -- 12. Molecular mechanisms and pharmacological implications of MMP-9 inhibition by ACE inhibition -- 13. Hypertension and angiotensin-converting enzyme inhibitors in rat cardiac microvessels - a mini review of histochemical microvascular studies -- 14. Action mechanism of angiotensin i-converting enzyme inhibitory peptides derived from cowpea (vigna unguiculata) -- 15. Effect of angiotensin-converting enzyme inhibitors on arterial stiffness and endothelial dysfunction: a comprehensive review
|
| 650 |
|
0 |
|a Angiotensin converting enzyme
|v Inhibitors
|x Therapeutic use
|
| 650 |
|
0 |
|a Angiotensin converting enzyme
|x Inhibitors
|
| 700 |
1 |
|
|a Onuigbo, Macaulay ,
|e author
|
| 999 |
|
|
|a 1000169202
|b Book
|c OPEN SHELF (30 DAYS)
|e Tembila Campus
|
| 999 |
|
|
|a 1000169203
|b Book
|c OPEN SHELF (30 DAYS)
|e Tembila Campus
|